Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

The following is a summary of “Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1,” published in the March 2025 issue of ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

one observational study from 2023 suggests a higher rate of migraine in people who have psoriasis. If you need immediate relief for an acute headache, ask a doctor whether over-the-counter ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

ORLANDO, Fla. — Adults with moderate to severe plaque psoriasis taking the novel oral drug icotrokinra had significant improvement starting at week 16, with increased response rates continuing ...

Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...

Acute inflammation is a short-term process occurring in response to tissue injury, usually appearing within minutes or hours. It is characterized by five cardinal signs: pain, redness, immobility ...

I have been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. My major current research work is ...

The core pathogenesis of psoriasis involves T-cell-dependent immune responses. Therefore, a few research studies have focused on whether B-cell-targeting therapy could be used. In this paper, we ...

Rosacea is more common among fair-skinned people ages 30 to 50 years. It's slightly more common in females rather than males. Even so, rosacea can develop at any age, even during childhood. These ...